International IP estate further strengthened for Feraccru

6 Sep 2017

Shield Therapeutics is pleased to announce that the United States Patent and Trademark Office (USPTO) has allowed a composition of matter patent protecting the active substance of Feraccru.

Please use the link provided below for the full announcement.

US Composition of Matter Patent Press Release

Back to news